Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
20m agoSunrun Prices $584 million Securitization of Residential Solar and Storage Assets
21m agoMadison Air Schedules First Quarter 2026 Earnings Conference Call and Webcast
44m agoUltra Clean Announces Retirement of the Chief Financial Officer Sheri Savage
45m agoGridAI Technologies Corp. Announces Receipt of NASDAQ Notice Regarding Late Form 10-K Filing
45m agoRush Enterprises, Inc. Reports First Quarter 2026 Results, Announces $0.19 Per Share Dividend

Camurus Ab

About

Camurus Ab (OTCGREY:CAMRF) — investor relations, events, news, and company updates on 6ix.

Latest News

Jan 9 2026
Camurus announces FDA acceptance of NDA resubmission for Oclaiz™ for the treatment of acromegaly
Nov 10 2025
Camurus reports positive topline results for CAM2056, semaglutide monthly depot
Aug 28 2025
Camurus announces approval of Oczyesa® for the treatment of acromegaly in the UK
Jul 1 2025
Camurus' Oczyesa® receives marketing authorization for treatment of acromegaly in the EU
Jun 18 2025
Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients

Financials

Revenue
$2.35 B
Market Cap
$3.29 B
P/E Ratio
42.31
EPS
1.30

Community Chat

Ask AI

6ix6ixAIEvents